AMERICAN SOCIETY OF PHARMACOGNOSY (EIN 591695079) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1959

Legal Domicile

Principal Officer

Susan Mooberry

Phone

7734748858

Tax Period

2025-01-01 to 2025-12-31

American Society of Pharmacognosy, founded in 1959, is a small nonprofit that reported $803K in total revenue in fiscal year 2018. Expenses of $721K left a modest 10% surplus.

Mission

To promote the growth and development of pharmacognosy to provide for association of workers in that science and related sciences to provide opportunities for presentation of research and achievements and to promote the publication of meritorious research.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $25,287

Program Service Revenue $632,204

Investment Income $132,055

Other Revenue $1,143

TOTAL REVENUE $790,689

Expense Breakdown

Grants Paid $0

Salaries & Benefits $105,891

Fundraising Expenses $0

Program Expenses $499,603

Other Expenses $589,142

TOTAL EXPENSES $695,033

Year-over-Year Comparison

	2025	2024	Change
Revenue	$790,689	$354,696	+1.2%
Expenses	$695,033	$326,430	+1.1%
Net Income	$95,656	$28,266	+2.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jimmy Orjala	Treasurer	5.00	Officer Director	$0	$0	$0
Joseph Betz	Past President	2.00	Officer Director	$0	$0	$0
Nandakumara Sarma	Assistant Treasurer	2.00	Director	$0	$0	$0
John H Cardellina	Foundation Chair	2.00	Director	$0	$0	$0
N/A	President	4.00	Officer Director	$0	$0	$0
Amy Keller	Secretary	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$790,689	$695,033	$1,377,981	$95,656
2024	$354,696	$326,430	$1,330,807	$28,266
2023	$810,488	$720,327	$1,252,892	$90,161
2022	$814,964	$798,679	$1,101,071	$16,285
2021	$445,247	$470,057	$1,216,392	$-24,810
2020	$465,618	$412,066	$1,175,990	$53,552
2019	$689,041	$629,201	$1,071,213	$59,840
2018	$803,142	$720,886	$910,086	$82,256

AMERICAN SOCIETY OF PHARMACOGNOSY